Patrizia Sini
Novartis Institute for Biomedical Research
Oncology Research
Basel
Switzerland
Name/email consistency: high
- The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade. Sini, P., Wyder, L., Schnell, C., O'Reilly, T., Littlewood, A., Brandt, R., Hynes, N.E., Wood, J. Clin. Cancer Res. (2005)